Michael Scolaro

Michael Scolaro

Oct 20, 2017

Group 6 Copy 115
0
    Please wait...

    About This Project

    We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

    Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Impact of Soylent Consumption on Human Microbiome Composition

    As students carry out their busy lifestyles, many are turning to inexpensive and convenient drink based...

    Does bias about medical diagnosis link to expectations of mental health problems for infants and their parents?

    If doctors think infants will have lower skill (e.g., less able to look and to smile at parents), does that...

    How do chemical exposures trigger autoimmune diseases?

    The cause of onset of autoimmune disease is poorly understood, but may be linked to exposure to certain...

    Backer Badge Funded